$7.3 million to translate nanomedicine research into advances in heart care
Miniscule, carefully engineered particles can detect the very beginning stages of clogged arteries in animals, thanks in large part to research at the School of Medicine. With a new five-year, $7.3 million grant, WUSM researchers will begin to translate this breakthrough into clinical advances.
New unit devoted to clinical neurology research
Clinical trials testing treatments for neurological disorders such as Parkinson’s disease and epilepsy soon will be conducted under one roof at the School of Medicine, adding critical mass to the neuroclinical research program and convenience for patients enrolled in clinical trials.
Evolution from Basic to Translational Research
P. Roy Vagelos, M.D., will present a lecture titled “Evolution from Basic to Translational Research (Washington University to Merck)” at noon Monday, November 29, in Cori Auditorium at Washington University School of Medicine. Vagelos was chairman of the Department of Biological Chemistry (currently the Department of Biochemistry and Molecular Biophysics) at the School of Medicine […]
Cancer imaging agent shortage is focus of $4.7 million grant
Scientists at Washington University have received a five-year, $4.7 million grant from the National Cancer Institute to explore new ways to produce, distribute and use radionuclides to detect cancers.
Volunteers needed to test treatment for post-shingles pain
Pain management researchers at the School of Medicine are recruiting people who have had shingles to test the effectiveness of an investigational drug designed to reduce the severe pain that can last for months or years after a bout with the disorder.
Hans Vonks widow raises awareness about her husbands illness
In an effort to learn about the latest research and treatments for amytrophic lateral sclerosis (ALS) and other nervous system diseases, the widow of Hans Vonk, former music director of the St. Louis Symphony Orchestra, will tour the newly established Hope Center for Neurological Disorders at the School of Medicine on Monday, Nov. 15.
Success of local company reflects strong start at Washington University
Originating in Washington University research laboratories, St. Louis-based biotechnology company Apath has generated enough profit in just seven years to contribute $1 million in royalty payments back to the School of Medicine.
Depression in preschoolers
Joan Luby helps identify depression in children with “interview puppets.”Although all children are sad sometimes, preschoolers tend to be inherently joyful. But Joan Luby, director of the Early Emotional Development Program at the School of Medicine, has found that, like adults, very young children can experience depression. Her research team has developed a checklist to help clinicians identify young children at risk for developing the disease.
Healthy habits key in absence of influenza vaccine
Washing hands can cut the risk of coming down with the flu.October saw long lines at flu vaccine locations as many people waited hours hoping for a shot. As health officials scramble to find doses of vaccine for those at high risk, a Washington University emergency medicine specialist at Barnes-Jewish Hospital in St. Louis says most of us may have to rely on hand washing and common sense if we want to stay healthy this winter.
Imaging technique detects plaques in Alzheimer’s disease
PET scans: normal (top 2 rows) and Alzheimer’s.After decades of searching, scientists finally may have identified a way to study Alzheimer’s disease changes in living human brains. Researchers at Washington University’s Alzheimer’s Disease Research Center (ADRC) have begun studies of an imaging agent developed at the University of Pittsburgh that could potentially detect amyloid plaques with a positron emission tomography (PET) scan, enabling earlier detection of the disease and improved testing of new treatments.
Older Stories